Simple Summary Tamoxifen, an antiestrogen, is a potent drug to treat and prevent hormone
dependent breast cancer. As it has low toxicity and is widely available, tamoxifen has …

Background Systematic pelvic and paraaortic lymphadenectomy has been widely used in the
surgical treatment of patients with advanced ovarian cancer, although supporting evidence …

OBJECTIVE.: CD24 is an established marker for poor prognosis in ovarian and other
carcinomas. Acquisition of cytoplasmic CD24, as opposed to membranous expression, has been …

Regulatory T-cells (Treg) have been the focus of immunologic research due to their role in
establishing tolerance for harmless antigens versus allowing immune responses against foes. …

Exosomes are membrane vesicles that are released from many different cell types. Tumor
derived-exosomes play a role in immune suppression. We hypothesized that in ovarian …

Introduction Molecular pathological research has contributed to improving the knowledge of
different subtypes of ovarian cancer. In parallel with the implementation of the new FIGO …

Purpose: To evaluate serum C-reactive protein (CRP) as prognostic variable in patients with
epithelial ovarian cancer (EOC). Experimental Design: In a multicenter study, preoperative …

Background: Women with node-positive vulvar cancer have a high risk for disease recurrence.
Indication criteria for adjuvant radiotherapy are controversial. This study was designed to …

Background: Granulosa cell tumor of the ovary is an uncommon neoplasm. The majority of
patients are diagnosed in early stages of disease and overall prognosis is favorable. The …

Purpose: The antibody–drug conjugate enfortumab vedotin (EV) releases a cytotoxic agent
into tumor cells via binding to the membrane receptor NECTIN-4. EV was recently approved …